Literature DB >> 26657851

Effect on Patient-Reported Outcomes of Debridement or Microfracture of Concomitant Full-Thickness Cartilage Lesions in Anterior Cruciate Ligament-Reconstructed Knees: A Nationwide Cohort Study From Norway and Sweden of 357 Patients With 2-Year Follow-up.

Jan Harald Røtterud1, Einar Andreas Sivertsen2, Magnus Forssblad3, Lars Engebretsen4, Asbjørn Årøen5.   

Abstract

BACKGROUND: The treatment of concomitant cartilage lesions in anterior cruciate ligament (ACL)-injured knees is debatable.
PURPOSE: To evaluate the effect of debridement or microfracture (MF) compared with no treatment of concomitant full-thickness (International Cartilage Repair Society [ICRS] grades 3-4) cartilage lesions on patient-reported outcomes after ACL reconstruction. STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: Six hundred forty-four patients who underwent primary unilateral ACL reconstruction and had a concomitant full-thickness cartilage lesion treated simultaneously by debridement (n = 129) or MF (n = 164), or underwent no treatment (n = 351) of the cartilage lesion, registered in the Norwegian and Swedish National Knee Ligament Registries from 2005 to 2008 were included. The Knee Injury and Osteoarthritis Outcome Score (KOOS) was used to measure patient-reported outcomes. At a mean follow-up of 2.1 ± 0.2 years after surgery, 357 (55%) patients completed the KOOS. Linear regression analyses were used to evaluate the effect of debridement or MF on the KOOS.
RESULTS: No significant effects of debridement were detected in the unadjusted or adjusted regression analyses on any of the KOOS subscales at 2-year follow-up. The MF treatment of the cartilage lesions had significant negative effects at 2-year follow-up on the KOOS Sport and Recreation (Sport/Rec) (regression coefficient [β] = -8.9; 95% confidence interval [CI], -15.1 to -1.5) and Knee-Related Quality of Life (QoL) (β = -8.1; 95% CI, -14.1 to -2.1) subscales in the unadjusted analyses. When adjusting for confounders, MF had significant negative effects on the same KOOS subscales of Sport/Rec (β = -8.6; 95% CI, -16.4 to -0.7) and QoL (β = -7.2; 95% CI, -13.6 to -0.8). For the remaining KOOS subscales of Pain, Symptoms, and Activities of Daily Living, there were no significant unadjusted or adjusted effects of MF.
CONCLUSION: MF of concomitant full-thickness cartilage lesions showed adverse effects on patient-reported outcomes at 2-year follow-up after ACL reconstruction. Debridement of concomitant full-thickness cartilage lesions showed neither positive nor negative effects on patient-reported outcomes at 2-year follow-up after ACL reconstruction.
© 2015 The Author(s).

Entities:  

Keywords:  KOOS; anterior cruciate ligament; articular cartilage; debridement; knee; microfracture

Mesh:

Year:  2015        PMID: 26657851     DOI: 10.1177/0363546515617468

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  12 in total

Review 1.  Do cartilage lesions affect the clinical outcome of anterior cruciate ligament reconstruction? A systematic review.

Authors:  Giuseppe Filardo; Francesca de Caro; Luca Andriolo; Elizaveta Kon; Stefano Zaffagnini; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-04       Impact factor: 4.342

2.  Wide Variation in Methodology in Level I and II Studies on Cartilage Repair: A Systematic Review of Available Clinical Trials Comparing Patient Demographics, Treatment Means, and Outcomes Reporting.

Authors:  Bryan Michael Saltzman; Michael L Redondo; Adam Beer; Eric J Cotter; Rachel M Frank; Adam B Yanke; Brian J Cole
Journal:  Cartilage       Date:  2018-10-31       Impact factor: 4.634

3.  Accurate Reporting of Concomitant Procedures Is Highly Variable in Studies Investigating Knee Cartilage Restoration.

Authors:  William L Sheppard; Betina B Hinckel; Armin Arshi; Seth L Sherman; Kristofer J Jones
Journal:  Cartilage       Date:  2019-04-11       Impact factor: 4.634

4.  Development of a pilot cartilage surgery register.

Authors:  Cathrine Nørstad Engen; Asbjørn Årøen; Lars Engebretsen
Journal:  BMC Musculoskelet Disord       Date:  2017-06-30       Impact factor: 2.362

Review 5.  Microfracture is more cost-effective than autologous chondrocyte implantation: a review of level 1 and level 2 studies with 5 year follow-up.

Authors:  Tommy Frøseth Aae; Per-Henrik Randsborg; Hilde Lurås; Asbjørn Årøen; Øystein Bjerkestrand Lian
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-11       Impact factor: 4.342

6.  Penny-wise and pound-foolish.

Authors:  Asbjørn Årøen; Brian M Devitt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-02-09       Impact factor: 4.342

7.  Concomitant full-thickness cartilage lesions do not affect patient-reported outcomes at minimum 10-year follow-up after ACL reconstruction.

Authors:  Katherine Wang; Cathrine N Eftang; Svend Ulstein; Asbjørn Årøen; Rune B Jakobsen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-10-09       Impact factor: 4.114

8.  Good validity in the Norwegian Knee Ligament Register: assessment of data quality for key variables in primary and revision cruciate ligament reconstructions from 2004 to 2013.

Authors:  Espen Midttun; Morten Torheim Andersen; Lars Engebretsen; Håvard Visnes; Anne Marie Fenstad; Jan-Erik Gjertsen; Andreas Persson
Journal:  BMC Musculoskelet Disord       Date:  2022-03-09       Impact factor: 2.362

9.  Partial Resurfacing of the Knee with the BioPoly Implant: Interim Report at 2 Years.

Authors:  Dinesh Nathwani; Michael McNicholas; Alister Hart; Jonathan Miles; Vladimir Bobić
Journal:  JB JS Open Access       Date:  2017-04-06

10.  A Controlled Comparison of Microfracture, Debridement, and No Treatment of Concomitant Full-Thickness Cartilage Lesions in Anterior Cruciate Ligament-Reconstructed Knees: A Nationwide Prospective Cohort Study From Norway and Sweden of 368 Patients With 5-Year Follow-up.

Authors:  Svend Ulstein; Asbjørn Årøen; Lars Engebretsen; Magnus Forssblad; Stein Håkon Låstad Lygre; Jan Harald Røtterud
Journal:  Orthop J Sports Med       Date:  2018-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.